| |
Maryland TEDCO Invests in Minkon Biotechnology
Junly 28, 2005 --
Maryland Technology Development Corporation (TEDCO) has recently awarded Minkon Biotechnology seed investment to
continue developing its anti-obesity technology. Minkon is now testing its first
product in animals to determine its efficiency for preventing obesity and
reducing excess fat accumulation. A nutraceutical (as defined as a food
additive, functional food, or dietary supplement), this product will provide a
safe dietary choice and functions to maintain normal fat reserves by targeting a
key metabolic pathway utilizing a technology patented by Minkon. Minkon
Biotechnology, Inc is developing series of products for weight control and
obesity treatment using its unique, proprietary technology. With a strong
collaboration between its industry partners and academic researchers, Minkon is
diligently pursuing its goals of addressing unmet medical needs, and improving
your life.
|
